Cargando…

OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data

Objectives: There are limited data on time spent in hypoglycemia range among older adults (≥ 60 yrs of age) with type 1 diabetes (T1D). We analyzed blinded continuous glucose monitoring (CGM) data collected at baseline in a randomized trial assessing the effect of CGM on hypoglycemia in older adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Anders, Kanapka, Lauren, Miller, Kellee, Ahmann, Andrew, Chaytor, Naomi, Fox, Steven, Kiblinger, Lisa, Kruger, Davida, Levy, Carol, Peters, Anne, Rickels, Michael, Salam, Maamoun, Shah, Viral, Young, Laura, Pratley, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554980/
http://dx.doi.org/10.1210/js.2019-OR22-2
_version_ 1783425065860202496
author Carlson, Anders
Kanapka, Lauren
Miller, Kellee
Ahmann, Andrew
Chaytor, Naomi
Fox, Steven
Kiblinger, Lisa
Kruger, Davida
Levy, Carol
Peters, Anne
Rickels, Michael
Salam, Maamoun
Shah, Viral
Young, Laura
Pratley, Richard
author_facet Carlson, Anders
Kanapka, Lauren
Miller, Kellee
Ahmann, Andrew
Chaytor, Naomi
Fox, Steven
Kiblinger, Lisa
Kruger, Davida
Levy, Carol
Peters, Anne
Rickels, Michael
Salam, Maamoun
Shah, Viral
Young, Laura
Pratley, Richard
author_sort Carlson, Anders
collection PubMed
description Objectives: There are limited data on time spent in hypoglycemia range among older adults (≥ 60 yrs of age) with type 1 diabetes (T1D). We analyzed blinded continuous glucose monitoring (CGM) data collected at baseline in a randomized trial assessing the effect of CGM on hypoglycemia in older adults with T1D. Methods: Data from 203 older adults with T1D enrolled in the Wireless Innovations for Seniors with Diabetes Mellitus (WISDM) study at 22 sites in the United States were analyzed. Eligibility criteria for the trial included age ≥60 yrs, no use of real-time CGM in the 3 months prior to enrollment and HbA1c <10.0%. All participants wore a blinded Dexcom G4 CGM at baseline for up to 21 days to collect at least 240 hours of CGM data. Associations of demographic and clinical characteristics with CGM-measured glucose levels and variability were assessed using linear regression models. Results: The analysis cohort included 203 participants; 52% female, median age of 68 years (IQR 65, 71), 93% non-Hispanic white and 53% used insulin pumps. Mean HbA1c was 7.5% (SD = 0.9%). Older adults spent a median of 5.0% of time <70 mg/dL (72 minutes per day) and 1.6% of time < 54 mg/dL (24 minutes per day). Impaired hypoglycemia awareness was associated with greater amounts of time spent with glucose levels < 70 and < 54 mg/dL, with a median % time <70 mg/dL of 7% vs. 5% (101 vs. 72 minutes per day, p=0.01) and median % time <54 mg/dL of 3% vs. 1% (43 vs. 14 minutes per day, p=0.008) in those with reduced awareness vs. those who were aware or uncertain. Participants spent a mean 56% of time in target glucose range of 70 to 180 mg/dL (13.4 hours per day), a median 35% of time above 180 mg/dL (8.4 hours per day), and a median 12% of time above 250 mg/dL (2.8 hours per day). Compared with participants who reported a status of “Employed” or “Unemployed”, participants reporting an employment status of “Retired” spent more time in target glucose range (p=0.003) and less time above 180 mg/dL (p=0.02) and above 250 mg/dL (p<0.001). Lower total daily insulin per kg was associated with having a higher percentage of glucose levels in range 70-180 mg/dL (p=0.02), a lower coefficient of variation (CV) and a lower percentage of glucose levels above 180 mg/dL (p=0.04) and above 250 mg/dL (p=0.008). Overall participants had a median CV of 42% with a higher CV observed among participants diagnosed at age <18 vs. adult onset (p=0.02). Conclusions: On review of blinded CGM data, older adults (≥60 yrs of age) with T1D spend over an hour a day in the hypoglycemic range and >100 minutes per day among those with impaired hypoglycemia awareness. Interventions to improve time in range and reduce biochemical hypoglycemia are needed to reduce the risk of severe hypoglycemia in this age group.
format Online
Article
Text
id pubmed-6554980
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65549802019-06-13 OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data Carlson, Anders Kanapka, Lauren Miller, Kellee Ahmann, Andrew Chaytor, Naomi Fox, Steven Kiblinger, Lisa Kruger, Davida Levy, Carol Peters, Anne Rickels, Michael Salam, Maamoun Shah, Viral Young, Laura Pratley, Richard J Endocr Soc Diabetes Mellitus and Glucose Metabolism Objectives: There are limited data on time spent in hypoglycemia range among older adults (≥ 60 yrs of age) with type 1 diabetes (T1D). We analyzed blinded continuous glucose monitoring (CGM) data collected at baseline in a randomized trial assessing the effect of CGM on hypoglycemia in older adults with T1D. Methods: Data from 203 older adults with T1D enrolled in the Wireless Innovations for Seniors with Diabetes Mellitus (WISDM) study at 22 sites in the United States were analyzed. Eligibility criteria for the trial included age ≥60 yrs, no use of real-time CGM in the 3 months prior to enrollment and HbA1c <10.0%. All participants wore a blinded Dexcom G4 CGM at baseline for up to 21 days to collect at least 240 hours of CGM data. Associations of demographic and clinical characteristics with CGM-measured glucose levels and variability were assessed using linear regression models. Results: The analysis cohort included 203 participants; 52% female, median age of 68 years (IQR 65, 71), 93% non-Hispanic white and 53% used insulin pumps. Mean HbA1c was 7.5% (SD = 0.9%). Older adults spent a median of 5.0% of time <70 mg/dL (72 minutes per day) and 1.6% of time < 54 mg/dL (24 minutes per day). Impaired hypoglycemia awareness was associated with greater amounts of time spent with glucose levels < 70 and < 54 mg/dL, with a median % time <70 mg/dL of 7% vs. 5% (101 vs. 72 minutes per day, p=0.01) and median % time <54 mg/dL of 3% vs. 1% (43 vs. 14 minutes per day, p=0.008) in those with reduced awareness vs. those who were aware or uncertain. Participants spent a mean 56% of time in target glucose range of 70 to 180 mg/dL (13.4 hours per day), a median 35% of time above 180 mg/dL (8.4 hours per day), and a median 12% of time above 250 mg/dL (2.8 hours per day). Compared with participants who reported a status of “Employed” or “Unemployed”, participants reporting an employment status of “Retired” spent more time in target glucose range (p=0.003) and less time above 180 mg/dL (p=0.02) and above 250 mg/dL (p<0.001). Lower total daily insulin per kg was associated with having a higher percentage of glucose levels in range 70-180 mg/dL (p=0.02), a lower coefficient of variation (CV) and a lower percentage of glucose levels above 180 mg/dL (p=0.04) and above 250 mg/dL (p=0.008). Overall participants had a median CV of 42% with a higher CV observed among participants diagnosed at age <18 vs. adult onset (p=0.02). Conclusions: On review of blinded CGM data, older adults (≥60 yrs of age) with T1D spend over an hour a day in the hypoglycemic range and >100 minutes per day among those with impaired hypoglycemia awareness. Interventions to improve time in range and reduce biochemical hypoglycemia are needed to reduce the risk of severe hypoglycemia in this age group. Endocrine Society 2019-04-30 /pmc/articles/PMC6554980/ http://dx.doi.org/10.1210/js.2019-OR22-2 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Diabetes Mellitus and Glucose Metabolism
Carlson, Anders
Kanapka, Lauren
Miller, Kellee
Ahmann, Andrew
Chaytor, Naomi
Fox, Steven
Kiblinger, Lisa
Kruger, Davida
Levy, Carol
Peters, Anne
Rickels, Michael
Salam, Maamoun
Shah, Viral
Young, Laura
Pratley, Richard
OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
title OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
title_full OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
title_fullStr OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
title_full_unstemmed OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
title_short OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
title_sort or22-2 exposure to hypoglycemia in older adults with type 1 diabetes: baseline characteristics using continuous glucose monitoring data
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554980/
http://dx.doi.org/10.1210/js.2019-OR22-2
work_keys_str_mv AT carlsonanders or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT kanapkalauren or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT millerkellee or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT ahmannandrew or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT chaytornaomi or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT foxsteven or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT kiblingerlisa or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT krugerdavida or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT levycarol or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT petersanne or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT rickelsmichael or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT salammaamoun or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT shahviral or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT younglaura or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata
AT pratleyrichard or222exposuretohypoglycemiainolderadultswithtype1diabetesbaselinecharacteristicsusingcontinuousglucosemonitoringdata